~~<i id='1BD1F8798E'><strike id='1BD1F8798E'><tt id='1BD1F8798E'><pre id='1BD1F8798E'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

entertainment

comprehensive

author：Wikipedia 2025-08-23 05:00:33 - browse：4

LONDON — GSK said Tuesday it would purchase the asthma-focused drug developer Aiolos Bio for $1 billion upfront, the latest in a string of pharma acquisitions that are bolstering hopes for the industry’s year ahead.

The deal includes up to another $400 million in payments if certain milestones are met.

Aiolos was launched just last year, based in both San Francisco and London. The company, which announced a $245 million Series A round in October, has been readying a Phase 2 trial of its candidate AIO-001 in adult asthma.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Anesthesiologist group: stop taking Ozempic before surgery
Next article： Vertex non

explore

focus

Wikipedia

knowledge

explore

hotspot

SenatehealthcommitteeChairBernieSanders(I-Vt.)wantstorewardnewmedicineswithprizemoney.JoseLuisMagana

WSS

How a Boston hospital is priming medical residents to use GPT

Physician groups backed by private equity giant lobby on mergers

Hormonal contraceptives don’t actually treat endometriosis

This biotech could one day make human eggs from scratch. But first, they’re trying to rethink IVF

Mystery swirls around US soldier who entered North Korea days ago, officials say

Judge denies Trump's request for new trial in E. Jean Carroll case

entertainment

comprehensive

explore

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Listen: Biogen's situation, Wegovy's risks, & biotech insider trading

Dobbs anniversary: the lost opportunity of abortion as health care

What to expect as Trump is arraigned on his Jan 6. indictment

In Memoriam: Notable people who died in 2023

There’s a way to spot data fakery. All journals should be using it

In Memoriam: Notable people who died in 2023

5 important ways Henrietta Lacks changed medical science

Virginia high school admissions case could be legal follow

Are infertility treatments 'essential' during the Covid

focus

'CMA Fest' 2023: How to watch, who is performing and more

Listen: Biogen's situation, Wegovy's risks, & biotech insider trading

New safety details link Apellis eye drug to rare cases of blindness

Micronoma's microbiome cancer diagnostic approach under fire

After a decade, new Gardasil ad campaign gets it (mostly) right

National panel will explore requiring free Covid tests

Wikipedia

knowledge

explore

hotspot